Discussing healthcare policy priorities in Strasbourg
News
4 May 2026
Healthcare

On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.

Related items

News
3 Nov 2026

A compass for better care

Beating cancer is one fight; protecting the heart through treatment is another. Heart-related complications are now the second leading cause of death among cancer survivors, and with diagnoses in Europe expected to rise 18% by 2040, the challenge will only grow. COMPASS, a €50.5 million initiative bringing together more than 60 partners, is building an AI-powered system that helps flag cardiotoxicity risk early and personalise care, so oncologists and cardiologists can act sooner and keep cancer treatment on track. GE HealthCare leads the industry side of the work, helping turn the research into everyday clinical practice across Europe. Read the full story on Invested in Europe.

Healthcare
Read more
Read more about A compass for better care
News
14 Jul 2026

Securing Europe’s place in global life sciences

On Tuesday, 14 July, AmCham EU hosted Csaba Kontor, Policy Assistant, Cabinet of European Commissioner Olivér Várhelyi, for a discussion on strengthening Europe’s competitiveness in the life sciences sector. Moderated by Katerina Valkova (Bristol Myers Squibb), Chair, Healthcare Committee, AmCham EU, the exchange explored how policy decisions can support investment through research and innovation while ensuring patients in Europe can access health innovation. Participants also discussed the importance of resilient EU-US supply chains and regulatory cooperation, as well as the need to avoid divergence and provide the scale and predictability required to sustain Europe’s position as a leading destination for life sciences investment.

Healthcare
Read more
Read more about Securing Europe’s place in global life sciences
News
24 Jun 2026

A medical milestone, made in Denmark

Pfizer selected Denmark as the site of the largest vaccine registry study ever undertaken, demonstrating how Europe can attract world-leading life sciences investment when the right conditions are in place. Beginning in 2024, Pfizer partnered with researchers at the Center for Translational Cardiology and Pragmatic Randomized Trials at Herlev-Gentofte Hospital in Copenhagen to assess whether its respiratory syncytial virus vaccine could reduce hospitalisations in adults. Denmark’s innovation-friendly environment, national digital mailbox eBoks and world-class health registries enabled researchers to invite almost the entire adult population to take part, helping recruit more than 500,000 participants. Study materials were made available online, allowing participants to provide informed consent from home, while health registries supported comprehensive tracking and analysis. This milestone shows how strong public-private collaboration and a supportive policy framework can help Europe deliver clinical research at scale and improve health outcomes for citizens. Read the full story on Invested in Europe. 

Healthcare
Read more
Read more about A medical milestone, made in Denmark